Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biochemical individuality and its implications for drug and carcinogen metabolism: recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans.

× No keyword cloud information.

12 in total

1. Influence of polymorphic metabolic enzymes on biotransformation and effects of diphenylmethane diisocyanate.

Authors: Margareta Littorin; Saimei Hou; Karin Broberg; Jonas Björk; Susanne Fält; Galbani Abdoulaye; Malgorzata Kalemba; Charlotta Ryk; Staffan Skerfving
Journal: Int Arch Occup Environ Health Date: 2007-08-04 Impact factor: 3.015

Review 2. Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors: M Pirmohamed; S Madden; B K Park
Journal: Clin Pharmacokinet Date: 1996-09 Impact factor: 6.447

3. Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease.

Authors: F Takakubo; M Yamamoto; N Ogawa; Y Yamashita; Y Mizuno; I Kondo
Journal: J Neural Transm (Vienna) Date: 1996 Impact factor: 3.575

4. Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population.

Authors: D S Ou-Yang; S L Huang; W Wang; H G Xie; Z H Xu; Y Shu; H H Zhou
Journal: Br J Clin Pharmacol Date: 2000-02 Impact factor: 4.335

5. Pharmacokinetics of a novel N-methyl-D-aspartate receptor antagonist (SM-18400): identification of an N-acetylated metabolite and pre-clinical assessment of N-acetylation polymorphism.

Authors: Masashi Yabuki; Yutaka Kon-Ya; Masaki Kataoka; Takeshi Shimizudani; Kyoko Akao; Masaki Ito; Hiroshi Kanamaru; Iwao Nakatsuka
Journal: Eur J Drug Metab Pharmacokinet Date: 2003 Jan-Mar Impact factor: 2.441

6. Nonparametric expectation maximisation (NPEM) population pharmacokinetic analysis of caffeine disposition from sparse data in adult caucasians: systemic caffeine clearance as a biomarker for cytochrome P450 1A2 activity.

Authors: Dimiter Terziivanov; Kristina Bozhinova; Velislava Dimitrova; Ivanka Atanasova
Journal: Clin Pharmacokinet Date: 2003 Impact factor: 6.447

7. Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.

Authors: Hiromasa Tsukino; Yoshiki Kuroda; Hiroyuki Nakao; Hirohisa Imai; Hisato Inatomi; Yukio Osada; Takahiko Katoh
Journal: J Cancer Res Clin Oncol Date: 2003-11-27 Impact factor: 4.553

Biochemical individuality and its implications for drug and carcinogen metabolism: recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans.